Sriphrapradang, Chutintorn http://orcid.org/0000-0001-8294-8601
Pinyopodjanard, Sittichai
Suntornlohanakul, Onnicha
Nimitphong, Hataikarn
Chirakalwasan, Naricha
Saetang, Sunee
Anothaisintawee, Thunyarat
Siwasaranond, Nantaporn
Manodpitipong, Areesa
Chailurkit, La-Or
Reutrakul, Sirimon
Funding for this research was provided by:
The Endocrine Society of Thailand (Not applicable)
Mahidol University (Not applicable)
Article History
Received: 15 August 2018
Revised: 18 October 2018
Accepted: 13 November 2018
First Online: 19 November 2018
Compliance with ethical standards
:
: HN received honoraria from Sanofi, Novo Nordisk, MSD, Takeda, Novartis, Amgen, and AstraZeneca. SR received a grant from MSD and honoraria from Sanofi, Medtronic, Novo Nordisk, and research equipment support from ResMed, Thailand. All other authors declare that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Written informed consent was obtained from all individual participants included in the study.